We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EC Leader Moves Device Oversight From Health to Internal Markets
EC Leader Moves Device Oversight From Health to Internal Markets
European trade groups and industry experts were cautiously optimistic regarding news that medtech oversight will move from the health directorate to industry, with some saying it will boost innovation and access to new therapies and others worried it could derail progress on regulatory reforms in the EU.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor